Physician profile
Ashish Bhatia
NPI 1104034545
$10,412.45
in general payments reported to CMS, 2019-2025
23 companies · $1,720 in 2025
The $1,720 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,323 · 2020: $1,061 · 2021: $1,354 · 2022: $1,304 · 2023: $1,719 · 2024: $1,930 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,341 · Education: $28.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,341.03 |
| Education | $28.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,185.25 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr |
| Abbott Laboratories | $2,600.82 | 2019-2025 | Ensite, Perclose Prostyle, Tacticath Ablation Catheter, Sensor Enabled |
| Kestra Medical Technology Services, INC. | $1,248.02 | 2022-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $928.27 | 2019-2024 | Xarelto |
| Pfizer INC. | $610.39 | 2019-2025 | |
| Medtronic, INC. | $550.41 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Arctic Front Advance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $353.37 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $265.44 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $145.42 | 2021-2024 | |
| Amgen INC. | $81.92 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $70.60 | 2019-2023 | Camzyos |
| Irhythm Technologies, INC. | $58.62 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Cordis US Corp. | $48.11 | 2025 | Mynx Control, Mynx Control Venous |
| Cardiofocus, INC. | $43.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $43.62 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $32.79 | 2024 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $27.93 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $27.70 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $22.72 | 2024 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.30 | 2019 | |
| Mayne Pharma Commercial LLC | $18.22 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $17.85 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.